Allspring Global Investments’s Antares Pharma, Inc. ATRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-119,866
Closed -$491K 3074
2022
Q1
$491K Sell
119,866
-26,574
-18% -$96.4K ﹤0.01% 2235
2021
Q4
$522K Buy
+146,440
New +$512K ﹤0.01% 2273

Other funds holding ATRS

Allspring Global Investments's ATRS Position: Q2 2022 in Review

Allspring Global Investments sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 119,866 shares — an estimated $491K sold.

Allspring Global Investments first reported a position in ATRS in Q4 2021 and held it in 2 quarters. The position peaked at $522K in Q4 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Allspring Global Investments reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Allspring Global Investments sold 119,866 Antares Pharma, Inc. shares in Q2 2022, an estimated $491K.
  • Allspring Global Investments first reported a position in Antares Pharma, Inc. in Q4 2021 and held it in 2 quarters.
  • Allspring Global Investments's Antares Pharma, Inc. position peaked at $522K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Allspring Global Investments's 13F filing for Q2 2022, filed 25 Jul 2022.